KIORA PHARMACEUTICALS INC·4

Mar 6, 2:03 PM ET

Daniels Eric Joseph 4

4 · KIORA PHARMACEUTICALS INC · Filed Mar 6, 2026

Research Summary

AI-generated summary of this filing

Updated

Kiora (KPRX) CDO Eric Daniels Withholds 238 Shares for Taxes

What Happened
Daniels Eric Joseph, Chief Development Officer of Kiora Pharmaceuticals (KPRX), had 238 shares withheld to satisfy an employee tax obligation related to a compensatory equity event. The shares were valued at $2.02 each, for a total withholding of approximately $481. The transaction is reported under code F (payment of exercise price or tax liability) and is a net share settlement rather than an open‑market sale.

Key Details

  • Transaction date: March 3, 2026
  • Report filed: March 6, 2026
  • Shares withheld/disposed: 238 shares at $2.02 each (total ≈ $481)
  • Transaction code: F — payment of exercise price or tax liability (net share settlement)
  • Shares owned after transaction: not specified in the provided filing
  • Remark: filing notes net share settlement; shares withheld to cover employee tax obligation

Context
Net share withholding is a routine administrative step when options vest or restricted shares are delivered; withheld shares are used to pay taxes and do not represent an open‑market sale or new investment decision. The small dollar value here ($~481) suggests this is an administrative tax withholding, not a material disposition.

Insider Transaction Report

Form 4
Period: 2026-03-03
Daniels Eric Joseph
Chief Development Officer
Transactions
  • Tax Payment

    Common Stock

    2026-03-03$2.02/sh238$48126,137 total
Signature
/s/ Melissa Tosca, Attorney-in-Fact|2026-03-06

Documents

1 file
  • 4
    wk-form4_1772823830.xmlPrimary

    FORM 4